Clinical Oncology NewsClinical Hematologic Review: Highlights from ASH and NEJM, JCO and BloodClinical Oncology NewsInvestigators from MD Anderson Cancer Center presented encouraging Phase II data showing ibrutinib (PCI-32765, Janssen) in combination w…
Worldwide cancer incidence predicted to rise by 75% by 2030 – PakistanToday.com.pk
PakistanToday.com.pkWorldwide cancer incidence predicted to rise by 75% by 2030PakistanToday.com.pkCountries with a higher HDI (such as Australia, Brazil, Russia and the United Kingdom) have higher rates of cancers associated with smoking (lung cancer)…
As families fail to fulfill body donors' pledge, govt to step in by amending law – Indian Express
|
As families fail to fulfill body donors‘ pledge, govt to step in by amending law
Indian Express With the number of such cases rising and the growing scarcity of donor bodies in medical colleges for the students to learn about Anatomy, the government has decided to be more strict and amend the Transplantation of Human Organ Act, 2011 by making it … |
One Million Americans with Blood Cancer in Jeopardy of Losing Access to … – PR Newswire (press release)
One Million Americans with Blood Cancer in Jeopardy of Losing Access to …PR Newswire (press release)Some of these include therapies for patients with chronic myelogenous leukemia such as imatinib, dastatinib, bosutinib, nilotinib and ponatinib; lenal…
Unmet Medical Need In Treatment Of Heart Failure Patients With Atrial … – TheStreet.com (press release)
|
Unmet Medical Need In Treatment Of Heart Failure Patients With Atrial …
TheStreet.com (press release) ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the Heart Failure … |
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial … – Fort Mills Times
|
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial …
Fort Mills Times ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the Heart Failure … |
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial … – Business Wire (press release)
|
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial …
Business Wire (press release) BUSINESS WIRE)–ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the … |
Foreign Risks Light Up for Philip Morris – Wall Street Journal (blog)
 Wall Street Journal (blog) |
Foreign Risks Light Up for Philip Morris
Wall Street Journal (blog) Decades of advertising bans, excise-tax increases and public-education campaigns have cut adults’ per capita cigarette consumption from a peak of 4,345 in 1963 to less than a quarter of that, according to the American Lung Association. Adding insult to … |
Dead businessman gives new lease of life to 7 – Times of India
Dead businessman gives new lease of life to 7Times of IndiaOfficials at the state-run Jeevandan, the comprehensive scheme envisaged to streamline organ donation programme in the state, said so far five livers and nine kidneys were retrieved and transpl…
Way to transplant organs without fall in immunity found – Hindustan Times
|
Way to transplant organs without fall in immunity found
Hindustan Times “Researchers infused T-regs in about 27 kidney patients so far after the transplantation. These patients underwent stem cell infusion, followed by kidney transplantation after immune testing and then T-reg infusion,” head of department of pathology … |